Edition · 2026-11-07

Saturday 7 November

Stop paying AI to do a script's job

AI-generated summary Adaptive6 co-founder and CTO Omer Müller states that the company uses artificial intelligence only for non-production tasks, internal one-offs, or product logic that cannot feasibly be codified. The company builds data pipelines, standard API integrations, and repetitive operational loops with robust, deterministic code rather than unsupervised artificial intelligence.

A rare strike in Taiwan exposes labor unrest beneath the global AI rush

Workers from the Micron Union participate in a protest, raising fists and speaking out in front of a banner

AI-generated summary About a dozen workers at a Micron Technology plant in Taoyuan in Taiwan went on strike in October after their union and the chipmaker failed to reach an agreement on salaries and bonuses. Micron on October 22 said it had reached an agreement with the Taichung union for higher salaries and quarterly bonuses, and bigger contributions to the pension accounts of all workers at its Taiwan operations.

Environmental groups turn to AI despite concerns over data center emissions By Investing.com

AI-generated summary Conservation organizations are adopting artificial intelligence to monitor wildlife and process environmental research despite concerns regarding the technology's growing energy and water demands. Groups such as the Jane Goodall Institute and Save the Elephants report significant efficiency gains from using technology from Amazon Web Services and Nvidia, while Greenpeace remains skeptical.

Also covered by thehill.com WIRED Tech Xplore
+1 moreThe Japan Times

AI Cancer Vaccine Achieves 75% Melanoma Response and 3-Year Remission: Evaxion Data at SITC 2026

Evaxion

AI-generated summary Evaxion A/S presented data at the Society for Immunotherapy of Cancer showing a 75% objective response rate for its personalized peptide cancer vaccine EVX-01 combined with Merck's pembrolizumab in advanced melanoma patients. Senior Scientist Mads Lausen of Evaxion presented systemic immunomodulatory findings examining how EVX-01 reshapes the immune system to support ongoing durability.